• University of Medicine 1, Yangon, Myanmar

• Attending physician, Division of Cardiology, Department of Internal Medicine, Taipei Veterans General Hospital

• Instructor of Medicine, National Yang Ming Chiao Tung University 

• Resident, Department of medicine, Heping branch, Taipei City Hospital
• Resident, Department of medicine, Taipei Veterans General Hospital
• Chief Resident, Division of Cardiology, Department of medicine, Taipei Veterans General Hospital
• Attending Physician, Division of Cardiology, Department of medicine, Keelung Hospital
• Attending Physician, Division of Cardiology, Department of medicine, Taipei Veterans General Hospital

• License of physician, Taiwan                            
• Specialist of Internal Medicine
• Specialist of Cardiovascular Medicine
• Specialist of Interventional Cardiology

• Heart failure
• Coronary artery disease
• Coronary intervention
• AV shunt/graft intervention
• Peripheral arterial disease

• cttsai2@vghtpe.gov.tw

1. Tsai CT, Huang WC, Lu TM, et al, Long term clinical impact of successful recanalization of chronic total occlusion in patients with and without type 2 diabetes mellitus, Cardiovascular diabetology 2020; 19: 119.
2. Tsai CT, Liao JN, Chao TF, Chen SA, et al, Association of ischemic stroke, major bleeding, and other adverse events with warfarin use vs non-vitamin K antagonist oral anticoagulant use in patients with atrial fibrillation with a history of intracranial hemorrhage. JAMA Network Open 2020; 3 (6): e206424.
3. Tsai CT, Lu YW, Huang PH, et al, Associations of antithrombotic agent use with clinical outcomes in critically ill patients with troponin I elevation in the absence of acute coronary syndrome. PLoS One. 2020;15(5): e0233178. 
4. Tsai CT, Liao JN, Chao TF, Chen SA, et al, Uninterrupted non-vitamin K antagonist oral anticoagulants during implantation of cardiac implantable electronic devices in patients with atrial fibrillation. J Chin Med Assoc 2019; 82 (4): 256 – 259.

限於篇幅,以上謹為代表著作